Prevalence and clinical-demographic correlates of hyperhomocysteinemia in inpatients with bipolar disorder in a Han Chinese population

Psychiatry Research

Volumn 259, Issue , 2018, Pages 364-369

  Zhou, Shuang Jiang ^a   Zhang, Li Gang ^a   Chen, Hong Mei ^a   Li, Ju Yan ^a   Li, Ran ^a   Zhang, Xi Mei ^a   Wang, Ning ^a   Soares, Jair C ^b   Cassidy, Ryan M ^b   Zheng, Yingjun ^c   Ning, Yuping ^c   Wang, Shao Li ^a   Chen, Jing Xu ^a   Zhang, Xiang Yang ^b,c  

^a PEKING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bipolar disorder; Body mass index; Homocysteine; Lithium; Prevalence; Valproate

Indexed keywords

HOMOCYSTEINE; LITHIUM; VALPROIC ACID;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BODY MASS; CHRONIC PATIENT; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EMOTIONAL DISORDER; FEMALE; GENDER; HAMILTON DEPRESSION RATING SCALE; HAN CHINESE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SMOKING HABIT; SYMPTOMATOLOGY; YOUNG MANIA RATING SCALE; BLOOD; CHINA; COMPLICATION; ETHNOLOGY; MIDDLE AGED; PSYCHOLOGY;

ADULT; BIPOLAR DISORDER; CHINA; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INPATIENTS; MALE; MIDDLE AGED; PREVALENCE;

EID: 85032923091     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2017.08.063     Document Type: Article

References (47)

1. Almeida, O.P., McCaul, K., Hankey, G.J., Norman, P., Jamrozik, K., Flicker, L., Homocysteine and depression in later life. Arch. Gen. Psychiatry 65 (2008), 1286–1294.
2. Awara, M.A., Zahid, S., Elnenaei, M.O., Rapid cycling bipolar affective disorder and recurrent strokes secondary to high bloodhomocysteine. J. Ment. Health 23:5 (2014), 276–279.
3. Baek, J.H., Bernstein, E.E., Nierenberg, A.A., One-carbon metabolism and bipolar disorder. Aust. N. Z. J. Psychiatry 47:11 (2013), 1013–1018.
4. Behzadi, A.H., Omrani, Z., Chalian, M., Asadi, S., Ghadiri, M., Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase ofmania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr. Scand. 120:6 (2009), 441–445.
5. Bochynska, A., Lipczyńska-Łojkowska, W., Gugała-Iwaniuk, M., Lechowicz, W., Restel, M., Graban, A., The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid. Seizure 21:4 (2012), 276–281.
6. Bromberg, A., Bersudsky, Y., Levine, J., Agam, G., Global leukocyte DNA methylation is not altered in euthymic bipolar patients. J. Affect. Disord. 118:1–3 (2009), 234–239.
7. Chiarani, F., Tramontina, J.F., Cereser, K.M., Kunz, M., Paim, L., Vargas, C.R., Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. Rev. Bras. Psiquiatr 35:2 (2013), 157–160.
8. Demmo, C., Lagerberg, T.V., Aminoff, S.R., Hellvin, T., Kvitland, L.R., Simonsen, C., Haatveit, B., Andreassen, O.A., Melle, I., Ueland, T., Course of neurocogitive function in first treatment bipolar I disorder: one-year follow-up study. Psychiatry Res. 249 (2017), 286–292.
9. Dias, V.V., Brissos, S., Cardoso, C., Andreazza, A.C., Kapczinski, F., Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. J. Affect Disord. 113:3 (2009), 285–290.
10. Dimitrova, K.R., DeGroot, K., Myers, A.K., Kim, Y.D., Estrogen and homocysteine. Cardiovasc. Res. 53 (2002), 577–588.
11. Dittmann, S., Seemuller, F., Schwarz, M.J., Kleindienst, N., Stampfer, R., Zach, J., Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord. 9:1–2 (2007), 63–70.
12. Dittmann, S., Seemuller, F., Grunze, H.C., Schwarz, M.J., Zach, J., Fast, K., The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J. Clin. Psychiatry 69:6 (2008), 899–906.
13. Doganavsargil Baysal, G.O., Gokmen, Z., Akbas, H., Cinemre, B., Metin, O., Karaman, T., Association of serum homocysteine and methionine levels with cognition and functioning in bipolar disorder. Turk. Psikiyatr. Derg. 24:1 (2013), 7–16.
14. Ellingrod, V.L., Taylor, S.F., Dalack, G., Grove, T.B., Bly, M.J., Brook, R.D., Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. J. Clin. Psychopharmacol. 32:2 (2012), 261–265.
15. Ezzaher, A., Mouhamed, D.H., Mechri, A., Omezzine, A., Neffati, F., Douki, W., Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry Clin. Neurosci. 65:7 (2011), 664–671.
16. Feussner, A., Rolinski, B., Weiss, N., Deufel, T., Wolfram, G., Roscher, A.A., Determination of total homocysteine in human plasma by isocratic high-performance liquid chromatography. Eur. J. Clin. Chem. Clin. Biochem. 35:9 (1997), 687–691.
17. Folstein, M., Liu, T., Peter, I., Buell, J., Arsenault, L., Scott, T., Qiu, W.W., The homocysteine hypothesis of depression. Am. J. Psychiatry 164:6 (2007), 861–867.
18. Frick, B., Schrocksnadel, K., Neurauter, G., Wirleitner, B., Artner-Dworzak, E., Fuchs, D., Rapid measurement of total plasma homocysteine by HPLC. Clin. Chim. Acta 331:1–2 (2003), 19–23.
19. Gao, L., Zeng, X.N., Guo, H.M., Wu, X.M., Chen, H.J., Di, R.K., Wu, Y., Cognitive and neurochemical alterations in hyperhomocysteinemic rat. Neurol. Sci. 33:1 (2012), 39–43.
20. Ghanizadeh, A., Singh, A.B., Berk, M., Torabi-Nami, M., Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies. Expert Opin. Ther. Targets 19:7 (2015), 927–939.
21. Gu, P., DeFina, L.F., Leonard, D., John, S., Weiner, M.F., Brown, E.S., Relationship between serum homocysteine levels and depressive symptoms: the Cooper Center Longitudinal Study. J. Clin. Psychiatry 73 (2012), 691–695.
22. Hankey, G.J., Eikelboom, J.W., Ho, W.K., van Bockxmeer, F.M., Clinical usefulness of plasma homocysteine in vascular disease. Med. J. Aust. 181:6 (2004), 314–318.
23. Hirsch, S., Poniachick, J., Avendano, M., Csendes, A., Burdiles, P., Smok, G., Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition 21:2 (2005), 137–141.
24. Karatela, R.A., Sainani, G.S., Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. Indian Heart J. 61:2 (2009), 156–159.
25. Levine, J., Sela, B.A., Osher, Y., Belmaker, R.H., High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 29:7 (2005), 1181–1191.
26. Li, L., Gao, P.J., Xi, R., Wu, C.F., Zhu, D.L., Yan, J., Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism. Clin. Exp. Pharmacol. Physiol. 35:12 (2008), 1471–1476.
27. Linnebank, M., Moskau, S., Semmler, A., Widman, G., Stoffel-Wagner, B., Weller, M., Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann. Neurol. 69:2 (2011), 352–359.
28. Lipton, S.A., Kim, W.K., Choi, Y.B., Kumar, S., D'Emilia, D.M., Rayudu, P.V., Arnelle, D.R., Stamler, J.S., Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. USA 94:11 (1997), 5923–5928.
29. Miller, C., Bauer, M.S., Excess mortality in bipolar disorders. Curr. Psychiatry Rep., 16(11), 2014, 499.
30. Mischoulon, D., Alpert, J.E., Arning, E., Bottiglieri, T., Fava, M., Papakostas, G.I., Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder. J. Clin. Psychiatry 73:6 (2012), 843–848.
31. Moustafa, A.A., Hewedi, D.H., Eissa, A.M., Frydecka, D., Misiak, B., Homocysteine levels in schizophrenia and affective disorders-focus on cognition. Front. Behav. Neurosci., 8, 2014, 343.
32. Narin, F., Atabek, M.E., Karakukcu, M., Narin, N., Kurtoglu, S., Gumus, H., The association of plasma homocysteine levels with serum leptin and apolipoprotein B levels in childhood obesity. Ann. Saudi Med. 25:3 (2005), 209–214.
33. Nilsson, T.K., Bottiger, A.K., Henriquez, P., Serra Majem, L., MTHFR polymorphisms and serum cobalamin affect plasma homocysteine concentrations differentially in females and males. Mol. Med. Rep. 10:5 (2014), 2706–2712.
34. Osher, Y., Sela, B.A., Levine, J., Belmaker, R.H., Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration. Bipolar Disord. 6:1 (2004), 82–86.
35. Osher, Y., Bersudsky, Y., Silver, H., Sela, B.A., Belmaker, R.H., Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J. Affect. Disord. 105:1–3 (2008), 229–233.
36. Peerbooms, O.L., van Os, J., Drukker, M., Kenis, G., Hoogveld, L., MTHFR in Psychiatry Group, Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?. Brain Behav. Immun. 25:8 (2011), 1530–1543.
37. Permoda-Osip, A., Dorszewska, J., Skibinska, M., Chlopocka-Wozniak, M., Rybakowski, J.K., Hyperhomocysteinemia in bipolar depression: clinical and biochemical correlates. Neuropsychobiology 68:4 (2013), 193–196.
38. Perlis, R.H., Ostacher, M.J., Patel, J.K., Marangell, L.B., Zhang, H., Wisniewski, S.R., Ketter, T.A., Miklowitz, D.J., Otto, M.W., Gyulai, L., Reilly-Harrington, N.A., Nierenberg, A.A., Sachs, G.S., Thase, M.E., Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (step-BD). Am. J. Psychiatry 163:2 (2006), 217–224.
39. Permoda-Osip, A., Kisielewski, J., Dorszewska, J., Rybakowski, J., Homocysteine and cognitive functions in bipolar depression. Psychiatr. Pol. 48:6 (2014), 1117–1126.
40. Purper-Ouakil, D., Porfirio, M.C., Le Strat, Y., Falissard, B., Gorwood, P., Masi, G., What do childhood attention deficit/hyperactivity symptoms in depressed adults tell us about the bipolar spectrum?. Psychiatry Res. 249 (2017), 244–251.
41. Träger, C., Decker, L., Wæhrens, E.E., Knorr, U., Miskowiak, K., Vinberg, M., Influences of patient informed cognitive complaints on activities of daily living in patients with bipolar disorder. An exploratory cross-sectional study. Psychiatry Res. 249 (2017), 268–274.
42. Trimmer, E.E., Methylenetetrahydrofolate reductase: biochemical characterization and medical significance. Curr. Pharm. Des. 19:14 (2013), 2574–2593.
43. Ubeda, N., Alonso-Aperte, E., Varela-Moreiras, G., Acute valproate administration impairs methionine metabolism in rats. J. Nutr. 132:9 (2002), 2737–2742.
44. Vaya, A., Ejarque, I., Tembl, J., Corella, D., Laiz, B., Hyperhomocysteinemia, obesity and cryptogenic stroke. Clin. Hemorheol. Microcirc. 47:1 (2011), 53–58.
45. Vuksan-Cusa, B., Sagud, M., Jakovljevic, M., Peles, A.M., Jaksic, N., Mihaljevic, S., Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia. Nord J. Psychiatry 67:5 (2013), 320–325.
46. Weiner, M., Warren, L., Fiedorowicz, J.G., Cardiovascular morbidity and mortality in bipolar disorder. Ann. Clin. Psychiatry 23:1 (2011), 40–47.
47. Zhang, L., Cao, X.L., Wang, S.B., Zheng, W., Ungvari, G.S., Ng, C.H., Zhong, B.L., Wang, G., Xiang, Y.T., The prevalence of bipolar disorder in China: a meta-analysis. J. Affect. Disord. 207 (2017), 413–421.